Abstract:Metabolic diseases dramatically affect the life of men and women from infancy up to old age in different and manifold ways and are a major challenge for the healthcare system. The treating physicians are confronted with the different needs of women and men in the clinical routine. Gender-specific differences affect pathophysiology, screening, diagnostic and treatment strategies of diseases as well as the development of complications and mortality rates. Impairments in glucose and lipid metabolism, regulation of energy balance and body fat distribution and therefore the associated cardiovascular diseases, are greatly influenced by steroidal and sex hormones. Furthermore, education, income and psychosocial factors play an important role in the development of obesity and diabetes differently in men and women. Males appear to be at greater risk of diabetes at a younger age and at a lower body mass index (BMI) compared to women but women feature a dramatic increase in the risk of diabetes-associated cardiovascular diseases after the menopause. The estimated future years of life lost owing to diabetes is somewhat higher in women than men, with a higher increase in vascular complications in women but a higher increase of cancer deaths in men. In women prediabetes or diabetes are more distinctly associated with a higher number of vascular risk factors, such as inflammatory parameters, unfavourable changes in coagulation and higher blood pressure. Women with prediabetes and diabetes have a much higher relative risk for vascular diseases. Women are more often morbidly obese and less physically active but may have an even greater benefit in health and life expectation from increased physical activity than men. In weight loss studies men often showed a higher weight loss than women; however, diabetes prevention is similarly effective in men and women with prediabetes with a risk reduction of nearly 40%. Nevertheless, a long-term reduction in all cause and cardiovascular mortality was so far only observed in women. Men predominantly feature increased fasting blood glucose levels, women often show impaired glucose tolerance. A history of gestational diabetes or polycystic ovary syndrome (PCOS) as well as increased androgen levels and decreased estrogen levels in women and the presence of erectile dysfunction or decreased testosterone levels in men are important sex-specific risk factors for the development of diabetes. Many studies showed that women with diabetes reach their target values for HbA1c, blood pressure and low-density lipoprotein (LDL)-cholesterol less often than their male counterparts, although the reasons are unclear. Furthermore, sex differences in the effects, pharmacokinetics and side effects of pharmacological treatment should be taken more into consideration.

Sex-based differences in insulin resistance

Sex differences in metabolic regulation and diabetes susceptibility

Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver

Gender Differences in Insulin Resistance: New Knowledge and Perspectives

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care

Consideration of sex as a biological variable in diabetes research across twenty years

Sex differences in type 2 diabetes

Sex Differences in the Skeletal Muscle Response to a High Fat, High Sucrose Diet in Rats

Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus

The sexual dimorphism of obesity

Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1

Sex Differences in the Burden and Complications of Diabetes

Sex Differences in Energy Metabolism: A Female-Oriented Discussion

Sexual dimorphism in the molecular mechanisms of insulin resistance during a critical developmental window in Wistar rats

[Sex and gender-specific aspects in prediabetes and diabetes mellitus-clinical recommendations (Update 2023)]

Sex-Specific Variation in Metabolic Responses to Diet

Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model

Transcriptomic landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue

Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity